Conventional therapy for atopic dermatitis

Immunology and Allergy Clinics of North America

Volumn 22, Issue 1, 2002, Pages 107-124

  Boguniewicz, Mark ^a,b   Nicol, Noreen ^a,b,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALCLOMETASONE DIPROPIONATE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUDESONIDE; CEPHALOSPORIN DERIVATIVE; CETIRIZINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; DESONIDE; DESOXIMETASONE; EMOLLIENT AGENT; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HALCINONIDE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; HYDROCORTISONE VALERATE; MOMETASONE FUROATE; PENICILLIN DERIVATIVE; PREDNISOLONE; PREDNISONE; PSEUDOMONIC ACID; TIXOCORTOL PIVALATE; TRIAMCINOLONE ACETONIDE; ULOBETASOL PROPIONATE; UNINDEXED DRUG;

ATOPIC DERMATITIS; CHRONIC DISEASE; CLINICAL TRIAL; FAMILY; HUMAN; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT PLANNING;

EID: 0036167451     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(03)00072-9     Document Type: Review

References (70)

1. Patch testing reactions to a standard series in 608 patients tested from 1990 to 1997 at Massachusetts General Hospital
2. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETAC. Early Treatment of the Atopic Child
3. New directions in allergic diseases: Mechanism-based anti-inflammatory therapies
4. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes
5. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis
6. Increasing incidence of eczema herpeticum: Analysis of seventy-five cases
7. The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis
8. Parental education in the treatment of childhood atopic eczema
9. Topical corticosteroid phobia in patients with atopic eczema
10. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge
11. Altered glucocorticoid binding in atopic dermatitis
12. Long-term efficacy of intranasal mupirocin ointment: A prospective cohort study of Staphylococcus aureus carriage
13. Treatment of itching in atopic eczema with antihistamines with a low sedative profile
14. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream
15. The soap chamber test: A new method for assessing the irritancy of soaps
16. "Wet wrap" dressings for the treatment of atopic eczema in children
17. Natural history of sensitizations in atopic dermatitis
18. Dose ranging study: Cetirizine in the treatment of atopic dermatitis in adults
19. Endogenous cortisol regulates immunoglobulin E-dependent late phase reaction
20. Effectiveness of occlusive bedding in the treatment of atopic dermatitis - A placebo-controlled trial of 12 months' duration
21. A preliminary study of psychological therapy in the management of atopic eczema
22. Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin?
23. Bactericidal activity of manganese and iodide ions against Staphylococcus aureus: A possible treatment for acute atopic dermatitis
24. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis
25. Psychotherapy for intractable inflammatory dermatoses
26. Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis
27. Mechanism of action of antipruritic drugs
28. Treatment of refractory cases of atopic dermatitis with acidic hot-spring bathing
29. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis: A multi-crossover-designed study
30. Modulation of the atopy patch test reaction by topical corticosteroids and tar
31. Double-blind study of cetirizine in atopic eczema in children
32. Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid
33. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: Mometasone furoate study group
34. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy
35. The case for steroid-antibiotic combinations
36. Staphylococcus aureus in the lesions of atopic dermatitis
37. Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products
38. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm)
39. A practical guide to topical therapy in children
40. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis
41. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children
42. "Wet wrap" dressings for the treatment of atopic eczema in the community
43. Contact allergy to corticosteroids
44. Cataracts, glaucoma, femoral avascular necrosis caused by topical corticosteroid ointment
45. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis
46. Atopic dermatitis: The (wet) wrap-up
47. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis
48. IgE-sensitization to cellular and culture filtrates of fungal extracts in patients with atopic dermatitis
49. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis
50. Utility of food-specific IgE concentrations in predicting symptomatic food allergy
51. Spontaneous basophil histamine release and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity
52. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
53. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren
54. Patch testing to detect corticosteroid allergy: Is it adequate?
55. Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream
56. Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management
57. Local steroid therapy and bacterial skin flora in atopic dermatitis
58. The vasoconstrictor assay in bioequivalence testing: Practical concerns and recent developments
59. Vasoconstrictor assay-specific applications
60. Biophysical assessment of persistent effects of moisturizers after their daily applications: Evaluation of corneotherapy
61. A twenty-four-hour occlusive exposure to 1% sodium lauryl sulfate induces a unique histopathologic inflammatory response in the xerotic skin of atopic dermatitis patients
62. Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis
63. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate
64. Skin-derived aeroallergenspecific T-cell clones of Th 2 phenotype in patients with atopic dermatitis
65. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in treatment of childhood atopic dermatitis
66. Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects
67. Successful treatment of therapy-resistant atopic dermatitis with clobetasol propionate and a hydrocolloid occlusive dressing
68. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis
69. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: Influence of corticosteroid dilution
70. Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis